Corrigendum to "Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial." [EClinicalMedicine 37 (2021) 100981].
Where this comes from
- Record sourced from PubMed, PMID 34805808.
- Also identified by DOI 10.1016/j.eclinm.2021.101203 and PMC identifier 8590842.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1016/j.eclinm.2021.100981.].